DNB Carnegie Investment Bank

DNB Carnegie is a leading Nordic investment bank formed through the strategic acquisition of Carnegie Holding AB by DNB Bank ASA in late 2024. The firm provides a comprehensive suite of financial services, including corporate finance advisory, equity research, and wealth management, with a specialized focus on the healthcare and life sciences sectors. As a dominant intermediary in Northern Europe, DNB Carnegie facilitates critical capital market activities such as initial public offerings, private placements, and mergers and acquisitions for biotechnology, medtech, and pharmaceutical companies. The organization leverages Carnegie's renowned research expertise and DNB's global distribution capabilities to support the growth of the Nordic healthcare ecosystem.